Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
X0303602	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2003-08-06	江苏豪森药业股份有限公司	Jiangsu Hansoh Pharmaceutical Group Co Ltd	Certificate Issued	2003-12-26	view
JYHZ2100648	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	License Renew	2021-10-12					view
JYHZ2100647	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	License Renew	2021-10-12					view
JYHZ1700037	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	License Renew	2017-08-03	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2018-01-16	view
JYHZ1700036	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	License Renew	2017-08-03	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2018-01-16	view
JYHZ0600025	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	License Renew	2006-09-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2008-04-03	view
JYHZ0600024	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	License Renew	2006-09-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2008-04-03	view
JYHZ0600023	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	License Renew	2006-09-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2008-04-03	view
JYHB2002634	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2020-12-21	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Filed	2021-01-06	view
JYHB2002633	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2020-12-21	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Filed	2021-01-06	view
JYHB2000595	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2020-05-18	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Filed	2020-06-03	view
JYHB2000594	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2020-05-18	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Filed	2020-06-03	view
JYHB1600585	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2016-05-23	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2016-12-12	view
JYHB1600584	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2016-05-23	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2016-12-12	view
JYHB1600583	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2016-05-23	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2016-12-12	view
JYHB1301562	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2013-12-05	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2014-06-19	view
JYHB1301561	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2013-12-05	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2014-06-19	view
JYHB1301557	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2013-12-05	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2014-06-19	view
JYHB1300748	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2013-06-18			Certificate Issued	2014-01-21	view
JYHB1300747	瑞格列奈片	repaglinide	Tablet	Chemical Drugs	Supplementary Application	2013-06-18			Certificate Issued	2014-01-21	view